glp-1 and no gallbladder Receptor Agonists: How Safe Are They for the Gallbladder? GLP-1 Without Gallbladder: Safety, Biomarkers

Clinical trials have shown that Semaglutide use is associated with a reduced incidence of cardiovascular events, including mortality, heart attack, and stroke in individuals with obesity

GLP-1 medications mimic the actions of a hormone called glucagon-like peptide-1

60 A recent systematic review found that there is little evidence for a physiologically relevant cephalic phase insulin response, although more than half of the studies examined documented its presence

Are microbiome changes responsible for metabolic improvements

Biologically derived nanocarriers such as virus-like particles (VLPs) offer a promising alternative